Hjem › Højt blodtryk › Kansas
Højt blodtryk kliniske forsøg i Kansas
11 studier for Højt blodtryk søger deltagere på steder i Kansas.
Byer i Kansas
Officiel studietekst (engelsk)
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
- University of Kansas Medical Center, Kansas City
- Cardiovascular Research Institute of Kansas, Wichita
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06059638EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- AMR El Dorado, El Dorado
- Cotton O'Neil Diabetes & Endocrinology Center, Topeka
- Tekton Research - Wichita, Wichita
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07064473A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Cotton O'Neil Clinical Research Center, Topeka
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07794579A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, Hutchinson
- Research Site, Kansas City
- Research Site, Wichita
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06742723Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Hutchinson
- Clinical Trial Site, Kansas City
- Clinical Trial Site, Topeka
- og 2 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT07181109Global Paradise System US Post Approval Study
- Ascension via Christi St. Francis, Wichita
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 12. aug. 2026 · NCT06297291A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
- Alliance for Multispecialty Research, Wichita
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 30. jul. 2026 · NCT07610278An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
- Alliance for Multispecialty Research, Wichita
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. jul. 2026 · NCT07543120Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
- Vanda Investigative Site, El Dorado
- Vanda Investigative Site, Wichita
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 27. feb. 2026 · NCT07090161Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
- University of Kansas Medical Center, Kansas City
RekruttererFase 1/2
Alder 35 til 65 · Alle køn · Opdateret 8. jun. 2025 · NCT04715022Reversing Glucose and Lipid-mediated Vascular Dysfunction
- University of Kansas Medical Center, Kansas City
RekruttererTidlig fase 1Frivillige med god helbredstilstand velkomne
Alder 18 til 79 · Alle køn · Opdateret 5. jun. 2025 · NCT04832009Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.